StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26−0.01 (-0.09%)

Close on Nov 18, 2026Market cap $248.90MP/E –Yield –

Amarin r&d expenses

Research and development expenses are spending on new products and technology.

Amarin's R&D Expenses for the twelve months ending Sep 30, 2026 was $19.01M, down 6.9% year over year. For fiscal 2025 it was $19.81M, down 5.1% from the year before. Over ten years it grew -9.0% a year on average. The highest annual figure on record is $72.75M in fiscal 2013.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.81M-5.1%
FY2024Dec 31, 2024$20.87M-6.1%
FY2023Dec 31, 2023$22.22M-26.9%
FY2022Dec 31, 2022$30.41M+3.8%
FY2021Dec 31, 2021$29.31M-24.8%
FY2020Dec 31, 2020$38.96M+13.3%
FY2019Dec 31, 2019$34.39M-38.5%
FY2018Dec 31, 2018$55.90M+18.5%
FY2017Dec 31, 2017$47.16M-5.6%
FY2016Dec 31, 2016$49.98M-2.1%
FY2015Dec 31, 2015$51.06M+1.5%
FY2014Dec 31, 2014$50.33M-30.8%
FY2013Dec 31, 2013$72.75M+23.4%
FY2012Dec 31, 2012$58.96M+172.9%
FY2011Dec 31, 2011$21.60M-22.9%
FY2010Dec 31, 2010$28.01M+34.1%
FY2009Dec 31, 2009$20.89M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$4.21M-0.1%
Q2 FY2026Jun 30, 2026$4.77M-2.9%
Q1 FY2026Mar 31, 2026$4.67M-12.2%
Q4 FY2025Dec 31, 2025$5.37M-10.3%
Q3 FY2025Sep 30, 2025$4.21M-7.3%
Q2 FY2025Jun 30, 2025$4.92M+3.6%
Q1 FY2025Mar 31, 2025$5.31M-5.1%
Q4 FY2024Dec 31, 2024$5.99M+3.4%
Q3 FY2024Sep 30, 2024$4.54M-11.1%
Q2 FY2024Jun 30, 2024$4.75M-15.9%
Q1 FY2024Mar 31, 2024$5.60M-1.5%
Q4 FY2023Dec 31, 2023$5.79M+10.5%
Q3 FY2023Sep 30, 2023$5.11M-11.4%
Q2 FY2023Jun 30, 2023$5.64M-39.7%
Q1 FY2023Mar 31, 2023$5.68M-43.5%
Q4 FY2022Dec 31, 2022$5.24M-8.9%
Q3 FY2022Sep 30, 2022$5.77M-26.3%
Q2 FY2022Jun 30, 2022$9.36M+47.2%
Q1 FY2022Mar 31, 2022$10.05M+7.2%
Q4 FY2021Dec 31, 2021$5.75M-32.4%
Q3 FY2021Sep 30, 2021$7.82M-23.4%
Q2 FY2021Jun 30, 2021$6.36M-36.2%
Q1 FY2021Mar 31, 2021$9.38M-8.8%
Q4 FY2020Dec 31, 2020$8.51M-23.3%
Q3 FY2020Sep 30, 2020$10.20M+14.4%
Q2 FY2020Jun 30, 2020$9.97M+39.8%
Q1 FY2020Mar 31, 2020$10.28M+41.9%
Q4 FY2019Dec 31, 2019$11.10M-6.8%
Q3 FY2019Sep 30, 2019$8.92M-36.6%
Q2 FY2019Jun 30, 2019$7.13M-60.7%
Q1 FY2019Mar 31, 2019$7.24M-38.4%
Q4 FY2018Dec 31, 2018$11.91M-0.3%
Q3 FY2018Sep 30, 2018$14.07M+31.6%
Q2 FY2018Jun 30, 2018$18.16M+32.6%
Q1 FY2018Mar 31, 2018$11.76M+8.7%
Q4 FY2017Dec 31, 2017$11.95M+17.4%
Q3 FY2017Sep 30, 2017$10.69M–
Q2 FY2017Jun 30, 2017$13.69M–
Q1 FY2017Mar 31, 2017$10.82M–
Q4 FY2016Dec 31, 2016$10.18M–

More Amarin figures

See a number that looks wrong?